- Home
- APLS vs EEFT Comparison
APLS vs EEFT Comparison
Compare APLS & EEFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- EEFT
- Stock Information
- Founded
- APLS 2009
- EEFT 1994
- Country
- APLS United States
- EEFT United States
- Employees
- APLS N/A
- EEFT N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- EEFT EDP Services
- Sector
- APLS Health Care
- EEFT Technology
- Exchange
- APLS Nasdaq
- EEFT Nasdaq
- Market Cap
- APLS 2.9B
- EEFT 3.5B
- IPO Year
- APLS 2017
- EEFT 1997
- Fundamental
- Price
- APLS $20.39
- EEFT $70.43
- Analyst Decision
- APLS Buy
- EEFT Strong Buy
- Analyst Count
- APLS 19
- EEFT 5
- Target Price
- APLS $32.83
- EEFT $117.60
- AVG Volume (30 Days)
- APLS 3.4M
- EEFT 1.0M
- Earning Date
- APLS 10-30-2025
- EEFT 10-22-2025
- Dividend Yield
- APLS N/A
- EEFT N/A
- EPS Growth
- APLS N/A
- EEFT N/A
- EPS
- APLS 0.36
- EEFT 6.78
- Revenue
- APLS $1,016,397,000.00
- EEFT $4,182,800,000.00
- Revenue This Year
- APLS $25.39
- EEFT $9.05
- Revenue Next Year
- APLS N/A
- EEFT $7.49
- P/E Ratio
- APLS $56.77
- EEFT $10.42
- Revenue Growth
- APLS 42.11
- EEFT 7.25
- 52 Week Low
- APLS $16.10
- EEFT $68.81
- 52 Week High
- APLS $35.72
- EEFT $114.25
- Technical
- Relative Strength Index (RSI)
- APLS 39.49
- EEFT 20.48
- Support Level
- APLS $18.93
- EEFT $71.14
- Resistance Level
- APLS $30.48
- EEFT $73.26
- Average True Range (ATR)
- APLS 1.29
- EEFT 1.88
- MACD
- APLS -0.37
- EEFT -0.30
- Stochastic Oscillator
- APLS 13.94
- EEFT 12.88
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About EEFT Euronet Worldwide Inc.
Euronet Worldwide Inc is a provider of electronic financial transaction solutions. It offers payment and transaction processing and distribution solutions to financial institutions, retailers, service providers, and individual consumers. The company's product offerings include comprehensive ATM, POS, card outsourcing, card issuing and merchant acquiring services, software solutions, money transfer services, etc. Its reportable operating segments are EFT Processing, epay, and Money Transfer. Maximum revenue is derived from its Money Transfer segment, which provides money transfer services across the world under the brand names Ria, AFEX, IME, and xe. Geographically, the company generates maximum revenue from the United States, followed by Germany, India, France, Greece, and other regions.